Vikramsinh M. Dabhi, M.D.

NPI 1609923879ActiveIndividual· Internal Medicine, Hematology & Oncology· Seattle, WA

Internal Medicine, Hematology & Oncology (M.D.) in Seattle, Washington, trained at University of Texas Southwestern Medical School at Dallas (class of 1998). Their prescriptions cost Medicare Part D more than their services did: $1,090,668 for 570 claims, against $543,319 paid for services in 2024. Takeda Pharmaceuticals U.S.A., Inc. was the largest of 3 companies reporting payments in 2024, $2,695 in all, mostly consulting fees.

Overview

NPI	1609923879
Status	Active
Entity type	Individual
Credential	M.D.
Sole proprietor	No
NPI issued	Jan 3, 2007
Last updated in NPPES	May 10, 2021
Certified by provider	May 10, 2021

Specialties and licenses

Taxonomy	Code	License	State
Internal Medicine, Hematology & Oncology Primary	207RH0003X	MD00040175	WA

About license numbers in NPPES

Exclusion screening

List	Result	Details
HHS-OIG LEIE · Nov 10, 2026	No match	Checked by NPI and by name + state
North Carolina Medicaid · Nov 11, 2026	No match	—
New York OMIG · Nov 11, 2026	No match	—
Ohio Medicaid · Nov 11, 2026	No match	—
Pennsylvania Medicheck · Nov 11, 2026	No match	—
Washington HCA · Nov 11, 2026	No match	—

Official OIG search · How matching works ·Bulk check a roster

Medicare

Enrollment (PECOS)	Enrolled Practitioner - Hematology/Oncology (WA)
Accepts assignment	Yes (participating)

Medicare services in 2024

Medicare patients	159
Services billed	34,092 across 98 procedure codes
Paid by Medicare	$543,319

Part D prescriptions in 2024

Prescriptions (claims)	570 · 1,075 30-day fills
Patients	118
Total drug cost	$1,090,668
Generic share	78% of claims

Medicare sources and data years

Education and affiliations

Medical school	University of Texas Southwestern Medical School at Dallas
Graduation year	1998
Medicare specialty	Hematology/Oncology
Secondary specialties	Internal Medicine
Telehealth	Offers telehealth